High molecular weight kininogen deficiency
|
0.770 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
High molecular weight kininogen deficiency
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
We conclude that a single base mutation in the kininogen gene exon 5 was responsible for kininogen deficiency in the Williams family.
|
7901207 |
1993 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Low C1-INH function results in overproduction of bradykinin, the primary cause of HAE symptoms.
|
22801442 |
2012 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Convincing data have also recently been published indicating that the clinical heterogeneity of hereditary angioedema due to C1 inhibitor deficiency (classified as C1-INH-HAE) could be attributed at least in part, either to the type of SERPING1 mutations or to mutations in genes encoding for enzymes involved in the metabolism and function of bradykinin.
|
27116602 |
2016 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hereditary and acquired angioedema due to C1-inhibitor deficiency (C1-INH-HAE and -AAE) are diseases characterized by serious and potentially fatal attacks of subcutaneous and submucosal edemas of upper airways, facial structures, abdomen, and extremities, due to inadequate control of BK generation.
|
27018196 |
2016 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
HAE is caused by SERPING1 gene mutations resulting in decreased or dysfunctional plasma protease C1 inhibitor (C1-INH) leading to a loss of inhibition of plasma kallikrein activity with subsequent cleavage of high-molecular weight kininogen and release of bradykinin.
|
31347612 |
2019 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is a form of bradykinin-mediated angioedema.
|
29214395 |
2018 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In this study, exon 1 nonanucleotide deletion polymorphism in the B2BKR gene was examined in 37 patients with hereditary angioedema.
|
12039525 |
2002 |
Angioedemas, Hereditary
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
To characterize the clinical profile, management and outcomes of patients with HAE type I and II from three specialist centres in the UK using data from the Icatibant Outcome Survey (IOS; Shire, Zug, Switzerland), an international observational study monitoring safety and effectiveness of icatibant, a selective bradykinin B2 receptor antagonist.
|
30127805 |
2018 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Association of the bradykinin receptors genes variants with hypertension: a case-control study and meta-analysis.
|
26362411 |
2016 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Sequence variation of bradykinin receptors B1 and B2 and association with hypertension.
|
15643125 |
2005 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
It was recently reported that a polymorphism of the bradykinin B2 receptor gene (BDKRB2) is a genetic predisposing factor for hypertension and cardiovascular disease.
|
15894833 |
2004 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
A meta-analysis of the bradykinin B2 receptor gene --58C/T polymorphism with hypertension.
|
20036225 |
2010 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Markers at the peroxisome proliferative activated receptor gamma coactivator 1α (PPARGC1A) and bradykinin β2 receptor (BDKRB2) genes were nominally associated with greater risk of hypertension, although one marker each at the BDKRB2 and endothelial nitric oxide synthase-3 (NOS3) genes were nominally associated with lower risk.
|
20944660 |
2011 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Polymorphisms of bradykinin B2 receptor (BDKRB2) gene are reported to be predisposing factors for hypertension.
|
22468762 |
2012 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Risk of bradykinin B2 receptor -58T/C gene polymorphism on hypertension: A meta-analysis.
|
27007662 |
2016 |
Hypertensive disease
|
0.400 |
GeneticVariation
|
group |
BEFREE |
Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension.
|
14499231 |
2003 |
Coughing
|
0.380 |
GeneticVariation
|
phenotype |
BEFREE |
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
|
11699055 |
2001 |
Coughing
|
0.380 |
GeneticVariation
|
phenotype |
BEFREE |
Several polymorphisms of the human bradykinin B(2) receptor gene may be involved in ACE inhibitor-related cough.
|
10904024 |
2000 |
Coughing
|
0.380 |
GeneticVariation
|
phenotype |
BEFREE |
We found no significant links between polymorphisms of the ACE gene or bradykinin B2 receptor gene with ACE inhibitor-induced coughing in hypertensive Koreans.
|
19744011 |
2009 |
anaphylaxis
|
0.360 |
GeneticVariation
|
phenotype |
BEFREE |
Nine patients experienced anaphylactic reactions due to bradykinin and six had to have their treatment changed.
|
18503695 |
2008 |
Venous Thromboembolism
|
0.120 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.
|
31420334 |
2019 |
Venous Thromboembolism
|
0.120 |
GeneticVariation
|
phenotype |
BEFREE |
Seven SNPs (F5 rs6025, F2 rs1799963, ABO rs514659, FGG rs2066865, F11 rs2289252, PROC rs1799810 and KNG1 rs710446) with four SNP-SNP interactions contributed to the genetic risk score for VTE, with an AUC of 0.66 (95% CI, 0.64-0.68).
|
25472531 |
2015 |
Cardiovascular Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Screening the human bradykinin B2 receptor gene in patients with cardiovascular diseases: identification of a functional mutation in the promoter and a new coding variant (T21M).
|
9880221 |
1998 |
Cardiovascular Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
It was recently reported that a polymorphism of the bradykinin B2 receptor gene (BDKRB2) is a genetic predisposing factor for hypertension and cardiovascular disease.
|
15894833 |
2004 |